Or Metastatic Breast Cancer
📧 Sign up to get email alerts when something new happens for Or Metastatic Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating JSKN003 against Trastuzumab, in combination with Pertuzumab and Docetaxel, as first-line therapy for HER…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) [Phase 3]
Phase 3 study evaluating Giredestrant with Phesgo versus Phesgo in locally advanced or metastatic breast cancer; the trial is currently acti…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules [Phase 1]
This Phase 1 trial evaluates increasing doses and different treatment schedules of the AKT inhibitor AZD5363 (ipatasertib) in patients with …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing Utidelone plus capecitabine versus a taxane plus capecitabine in HER2-negative locally advanced or metastatic breast…